These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3920457)

  • 21. American Academy of Pediatrics Committee on Drugs: Valproic acid: benefits and risks.
    Pediatrics; 1982 Aug; 70(2):316-9. PubMed ID: 6808453
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G; Marková J; Mastík J
    Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent pancreatitis induced by valproic acid. A case report and review of the literature.
    Parker PH; Helinek GL; Ghishan FK; Greene HL
    Gastroenterology; 1981 Apr; 80(4):826-8. PubMed ID: 6162706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate-induced tinnitus misinterpreted as psychotic symptoms.
    Reeves RR; Mustain DW; Pendarvis JE
    South Med J; 2000 Oct; 93(10):1030-1. PubMed ID: 11147471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate: a new cause of birth defects--report from Italy and follow-up from France.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1983 Aug; 32(33):438-9. PubMed ID: 6410178
    [No Abstract]   [Full Text] [Related]  

  • 27. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
    Joffe H; Cohen LS; Suppes T; Hwang CH; Molay F; Adams JM; Sachs GS; Hall JE
    Biol Psychiatry; 2006 Dec; 60(12):1378-81. PubMed ID: 16950230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of bipolar affective illnesses with valproate. A review of the literature].
    Retzow A; Emrich HM
    Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Side effects of sodium valproate.
    Cowan A
    Neurology; 1980 Mar; 30(3):336. PubMed ID: 6767202
    [No Abstract]   [Full Text] [Related]  

  • 30. Does valproate pose a threat to human immunodeficiency virus-infected patients?
    Hardy MA; Nardacci D
    J Clin Psychopharmacol; 1999 Apr; 19(2):189-90. PubMed ID: 10211926
    [No Abstract]   [Full Text] [Related]  

  • 31. Do valproate preparations improve agitation in dementia? A Cochrane Review summary with commentary.
    Lindley RI
    Australas J Ageing; 2021 Sep; 40(3):336-338. PubMed ID: 34390114
    [No Abstract]   [Full Text] [Related]  

  • 32. Award people in England harmed by mesh or valproate interim £25 000, says safety commissioner.
    Kmietowicz Z
    BMJ; 2024 Feb; 384():q303. PubMed ID: 38325878
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 34. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Valproate--new data on metabolism and severe side effects].
    Jameson S; Bjurstam N
    Lakartidningen; 1985 Feb; 82(9):679-81. PubMed ID: 3920457
    [No Abstract]   [Full Text] [Related]  

  • 36. [Valproate-caused encephalopathy].
    Thygesen KS; Wolf P
    Ugeskr Laeger; 2005 Oct; 167(40):3793-4. PubMed ID: 16221398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The anti-epileptic effect of valproate, side-effects and toxicity].
    Nielsen CJ; Christensen TL; Lund M
    Ugeskr Laeger; 1981 Aug; 143(32):2031-4. PubMed ID: 6797119
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.